CRI’s 5th Annual Wear White Luncheon Raises Over $40,000 June 25, 2024July 10, 2024 CRI Staff Hosts Mary Jo Bramson and Pamela Bringsjord (center) gather outside with all luncheon attendees and speakers. On Thursday, June 20, 2024, the Cancer Research Institute (CRI) celebrated its fifth annual Wear White Luncheon, hosted by Mary Jo Bramson and Pamela Bringsjord. Over 40 attendees gathered at the historic Sleepy Hollow Country Club in Briarcliff Manor, NY to learn about how far cancer immunotherapy has come in the past 70+ years, and the future of the field with CRI at the forefront. To symbolize CRI’s mission to save more lives by fueling the discovery and development of powerful immunotherapies for all cancers, guests were asked to wear white, representing all colors of the different cancer ribbons combined. Linnea Elliott shares how immunotherapy saved her life. Attendees were noticeably moved as they listened to stage 3 lung cancer survivor and CRI ImmunoAdvocate, Linnea Elliott, share her personal experience with immunotherapy. After a shocking diagnosis despite showing zero symptoms, she enrolled in a clinical trial. With the help of her oncologists at Memorial Sloan Kettering Cancer Center, 77 days later and after just two doses of an immunotherapy infusion, Linnea was cured. “I said, cured? I had never heard of cured before… But they said, no, you’re cured,” Elliot said. Dr. Miriam Merad (left) answers questions from CRI’s Chief Executive Officer and Director of Scientific Affairs, Dr. Jill O’Donnell-Tormey (right). Guests also had the honor of hearing from internationally renowned physician and scientist Miriam Merad MD, PhD, a member of CRI’s Scientific Advisory Council, and Director of the Marc and Jennifer Lipschultz Precision Immunology Institute at Mount Sinai School of Medicine. Dr. Merad also serves as the Director of the Mount Sinai Human Immune Monitoring Center. Dr. Merad spoke with excitement about the impressive work her lab is doing in the fields of dendritic cell and macrophage biology, with a focus on their contribution to cancer and inflammatory diseases. “This type of research is so critically important because it brings information and knowledge that was never even possible before,” Dr. Merad said during the luncheon. In total, the event raised over $40,000. CRI extends its immense gratitude to co-hosts Mary Jo and Pamela, and to all who took part in this event to raise funds for a world immune to cancer. Read more: Post navigation Keytruda Receives 40th FDA Approval Read Story What’s in Your Glass? Weighing the Health Risks of Alcohol Consumption Read Story
